English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Michael N. Oxman,1,2 Ruth Harbecke,1,3 and David M. Koelle4,5,6 1Department of Medicine, Division of Infectious Diseases, University of California, San Diego, La Jolla; 2Medicine Service, Infectious Diseases Section and 3Research Service, Veterans Affairs San Diego Healthcare System, California; and 4Departments of Medicine, Laboratory Medicine, and Global Health, University of Washington, 5Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, and 6Benaroya Research Institute, Seattle, Washington

the journal of infectious diseases (online. university of chicago press)/the journal of infectious diseases

Clinical Usage of the Adjuvanted Herpes Zoster Subunit Vaccine (HZ/su): Revaccination of Recipients of Live Attenuated Zoster Vaccine and Coadministration With a Seasonal Influenza Vaccine